{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:48:02Z","timestamp":1790610482809,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T00:00:00Z","timestamp":1686528000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T00:00:00Z","timestamp":1686528000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["U24-CA210967"],"award-info":[{"award-number":["U24-CA210967"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["U24-CA271037"],"award-info":[{"award-number":["U24-CA271037"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"DOI":"10.13039\/100010661","name":"EC | Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["101017453"],"award-info":[{"award-number":["101017453"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Recent interest in targeted therapies has been sparked by the study of MHC-associated peptides (MAPs) that undergo post-translational modifications (PTMs), particularly glycosylation. In this study, we introduce a fast computational workflow that merges the\u00a0MSFragger-Glyco search algorithm with a false discovery rate control for glycopeptide analysis from mass spectrometry-based immunopeptidome data. By analyzing eight large-scale publicly available studies, we find that glycosylated MAPs are predominantly presented by MHC class II. Here, we present HLA-Glyco, a comprehensive resource containing over 3,400 human leukocyte antigen (HLA) class II N-glycopeptides from 1,049 distinct protein glycosylation sites. This resource provides valuable insights, including high levels of truncated glycans, conserved HLA-binding cores, and differences in glycosylation positional specificity between HLA allele groups. We integrate the workflow within the FragPipe computational platform and provide HLA-Glyco as a free web resource. Overall, our work provides a valuable tool and resource to aid the nascent field of glyco-immunopeptidomics.<\/jats:p>","DOI":"10.1038\/s41467-023-39270-2","type":"journal-article","created":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T11:01:56Z","timestamp":1686567716000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Unraveling the glycosylated immunopeptidome with HLA-Glyco"],"prefix":"10.1038","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3086-3742","authenticated-orcid":false,"given":"Georges","family":"Bedran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0515-1735","authenticated-orcid":false,"given":"Daniel A.","family":"Polasky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9435-0305","authenticated-orcid":false,"given":"Yi","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7695-3698","authenticated-orcid":false,"given":"Fengchao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8228-5374","authenticated-orcid":false,"given":"Felipe","family":"da Veiga Leprevost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5553-6991","authenticated-orcid":false,"given":"Javier A.","family":"Alfaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin","family":"Cieslik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2806-7819","authenticated-orcid":false,"given":"Alexey I.","family":"Nesvizhskii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,12]]},"reference":[{"key":"39270_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/glycob\/cww086","volume":"27","author":"A Varki","year":"2017","unstructured":"Varki, A. Biological roles of glycans. Glycobiology 27, 3\u201349 (2017).","journal-title":"Glycobiology"},{"key":"39270_CR2","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.trecan.2020.04.002","volume":"6","author":"AF Costa","year":"2020","unstructured":"Costa, A. F., Campos, D., Reis, C. A. & Gomes, C. Targeting glycosylation: a new road for cancer drug discovery. Trends Cancer 6, 757\u2013766 (2020).","journal-title":"Trends Cancer"},{"key":"39270_CR3","doi-asserted-by":"publisher","first-page":"188464","DOI":"10.1016\/j.bbcan.2020.188464","volume":"1875","author":"D Thomas","year":"2021","unstructured":"Thomas, D., Rathinavel, A. K. & Radhakrishnan, P. Altered glycosylation in cancer: a promising target for biomarkers and therapeutics. Biochim. Biophys. Acta BBA Rev. Cancer 1875, 188464 (2021).","journal-title":"Biochim. Biophys. Acta BBA Rev. Cancer"},{"key":"39270_CR4","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1515\/cclm-2018-0379","volume":"57","author":"M Wang","year":"2019","unstructured":"Wang, M., Zhu, J., Lubman, D. M. & Gao, C. Aberrant glycosylation and cancer biomarker discovery: a promising and thorny journey. Clin. Chem. Lab. Med. 57, 407\u2013416 (2019).","journal-title":"Clin. Chem. Lab. Med."},{"key":"39270_CR5","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ccell.2019.06.006","volume":"36","author":"S Mereiter","year":"2019","unstructured":"Mereiter, S., Balma\u00f1a, M., Campos, D., Gomes, J. & Reis, C. A. Glycosylation in the era of cancer-targeted therapy: where are we heading? Cancer Cell 36, 6\u201316 (2019).","journal-title":"Cancer Cell"},{"key":"39270_CR6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s42485-021-00066-x","volume":"12","author":"KK Mangalaparthi","year":"2021","unstructured":"Mangalaparthi, K. K. et al. Digging deeper into the immunopeptidome: characterization of post-translationally modified peptides presented by MHC I. J. Proteins Proteom. 12, 151\u2013160 (2021).","journal-title":"J. Proteins Proteom."},{"key":"39270_CR7","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1074\/mcp.RA119.001846","volume":"19","author":"S Mei","year":"2020","unstructured":"Mei, S. et al. Immunopeptidomic analysis reveals that deamidated HLA-bound peptides arise predominantly from deglycosylated precursors. Mol. Cell. Proteom. 19, 1236\u20131247 (2020).","journal-title":"Mol. Cell. Proteom."},{"key":"39270_CR8","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0161-5890(95)00143-3","volume":"33","author":"G Carra","year":"1996","unstructured":"Carra, G. Selective association of a 22\u201338 kDa glycoprotein with MHC class II DP antigen on activated human lymphocytes at the plasma membrane. Mol. Immunol. 33, 269\u2013278 (1996).","journal-title":"Mol. Immunol."},{"key":"39270_CR9","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1021\/acs.jproteome.6b00496","volume":"16","author":"SA Malaker","year":"2017","unstructured":"Malaker, S. A. et al. Identification and characterization of complex glycosylated peptides presented by the MHC Class II processing pathway in Melanoma. J. Proteome Res. 16, 228\u2013237 (2017).","journal-title":"J. Proteome Res."},{"key":"39270_CR10","doi-asserted-by":"publisher","first-page":"573928","DOI":"10.3389\/fimmu.2020.573928","volume":"11","author":"A Olvera","year":"2021","unstructured":"Olvera, A. et al. Does antigen glycosylation impact the HIV-specific T cell immunity? Front. Immunol. 11, 573928 (2021).","journal-title":"Front. Immunol."},{"key":"39270_CR11","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/j.1440-1711.2005.01347.x","volume":"83","author":"Y Xu","year":"2005","unstructured":"Xu, Y., Sette, A., Sidney, J., Gendler, S. J. & Franco, A. Tumor\u2010associated carbohydrate antigens: A possible avenue for cancer prevention. Immunol. Cell Biol. 83, 440\u2013448 (2005).","journal-title":"Immunol. Cell Biol."},{"key":"39270_CR12","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.1002\/1521-4141(200109)31:9<2690::AID-IMMU2690>3.0.CO;2-8","volume":"31","author":"F Housseau","year":"2001","unstructured":"Housseau, F. et al. N-linked carbohydrates in tyrosinase are required for its recognition by human MHC class II-restricted CD4+ T cells. Eur. J. Immunol. 31, 2690\u20132701 (2001).","journal-title":"Eur. J. Immunol."},{"key":"39270_CR13","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.4049\/jimmunol.180.6.4011","volume":"180","author":"H Li","year":"2008","unstructured":"Li, H. et al. Identification of an N-linked glycosylation in the C4 region of HIV-1 envelope gp120 that is critical for recognition of neighboring CD4 T cell epitopes. J. Immunol. 180, 4011\u20134021 (2008).","journal-title":"J. Immunol."},{"key":"39270_CR14","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1074\/mcp.O115.057638","volume":"15","author":"M Thaysen-Andersen","year":"2016","unstructured":"Thaysen-Andersen, M., Packer, N. H. & Schulz, B. L. Maturing glycoproteomics technologies provide unique structural insights into the N-glycoproteome and its regulation in health and disease. Mol. Cell. Proteom. 15, 1773\u20131790 (2016).","journal-title":"Mol. Cell. Proteom."},{"key":"39270_CR15","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1038\/s41592-021-01209-0","volume":"18","author":"J Shen","year":"2021","unstructured":"Shen, J. et al. StrucGP: de novo structural sequencing of site-specific N-glycan on glycoproteins using a modularization strategy. Nat. Methods 18, 921\u2013929 (2021).","journal-title":"Nat. Methods"},{"key":"39270_CR16","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1038\/s41592-021-01306-0","volume":"18","author":"W-F Zeng","year":"2021","unstructured":"Zeng, W.-F., Cao, W.-Q., Liu, M.-Q., He, S.-M. & Yang, P.-Y. Precise, fast and comprehensive analysis of intact glycopeptides and modified glycans with pGlyco3. Nat. Methods 18, 1515\u20131523 (2021).","journal-title":"Nat. Methods"},{"key":"39270_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29530-y","volume":"13","author":"Z Fang","year":"2022","unstructured":"Fang, Z. et al. Glyco-Decipher enables glycan database-independent peptide matching and in-depth characterization of site-specific N-glycosylation. Nat. Commun. 13, 1900 (2022).","journal-title":"Nat. Commun."},{"key":"39270_CR18","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/jms.780","volume":"40","author":"J Dengjel","year":"2005","unstructured":"Dengjel, J., Rammensee, H.-G. & Stevanovic, S. Glycan side chains on naturally presented MHC class II ligands. J. Mass Spectrom. 40, 100\u2013104 (2005).","journal-title":"J. Mass Spectrom."},{"key":"39270_CR19","doi-asserted-by":"publisher","first-page":"109179","DOI":"10.1016\/j.celrep.2021.109179","volume":"35","author":"R Parker","year":"2021","unstructured":"Parker, R. et al. Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cells. Cell Rep. 35, 109179 (2021).","journal-title":"Cell Rep."},{"key":"39270_CR20","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nmeth.4256","volume":"14","author":"AT Kong","year":"2017","unstructured":"Kong, A. T., Leprevost, F. V., Avtonomov, D. M., Mellacheruvu, D. & Nesvizhskii, A. I. MSFragger: ultrafast and comprehensive peptide identification in mass spectrometry\u2013based proteomics. Nat. Methods 14, 513 (2017).","journal-title":"Nat. Methods"},{"key":"39270_CR21","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1038\/s41592-020-0967-9","volume":"17","author":"DA Polasky","year":"2020","unstructured":"Polasky, D. A., Yu, F., Teo, G. C. & Nesvizhskii, A. I. Fast and comprehensive N- and O-glycoproteomics analysis with MSFragger-Glyco. Nat. Methods 17, 1125\u20131132 (2020).","journal-title":"Nat. Methods"},{"key":"39270_CR22","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nature22991","volume":"547","author":"PA Ott","year":"2017","unstructured":"Ott, P. A. et al. An immunogenic personal neoantigen vaccine for patients with melanoma. Nature 547, 217\u2013221 (2017).","journal-title":"Nature"},{"key":"39270_CR23","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/s41586-022-04682-5","volume":"605","author":"G Oliveira","year":"2022","unstructured":"Oliveira, G. et al. Landscape of helper and regulatory antitumour CD4+ T cells in melanoma. Nature 605, 532\u2013538 (2022).","journal-title":"Nature"},{"key":"39270_CR24","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1158\/1078-0432.CCR-18-3200","volume":"25","author":"ML Axelrod","year":"2019","unstructured":"Axelrod, M. L., Cook, R. S., Johnson, D. B. & Balko, J. M. Biological consequences of MHC-II expression by tumor cells in cancer. Clin. Cancer Res. 25, 2392\u20132402 (2019).","journal-title":"Clin. Cancer Res."},{"key":"39270_CR25","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1038\/s41586-019-1671-8","volume":"574","author":"E Alspach","year":"2019","unstructured":"Alspach, E. et al. MHC-II neoantigens shape tumour immunity and response to immunotherapy. Nature 574, 696\u2013701 (2019).","journal-title":"Nature"},{"key":"39270_CR26","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41417-020-0183-x","volume":"28","author":"RE Tay","year":"2021","unstructured":"Tay, R. E., Richardson, E. K. & Toh, H. C. Revisiting the role of CD4+ T cells in cancer immunotherapy\u2014new insights into old paradigms. Cancer Gene Ther. 28, 5\u201317 (2021).","journal-title":"Cancer Gene Ther."},{"key":"39270_CR27","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.4049\/jimmunol.1900778","volume":"204","author":"AM Johnson","year":"2020","unstructured":"Johnson, A. M. et al. Cancer cell\u2013intrinsic expression of MHC class II regulates the immune microenvironment and response to anti\u2013PD-1 therapy in lung adenocarcinoma. J. Immunol. 204, 2295\u20132307 (2020).","journal-title":"J. Immunol."},{"key":"39270_CR28","doi-asserted-by":"publisher","first-page":"796584","DOI":"10.3389\/fimmu.2021.796584","volume":"12","author":"S Mukherjee","year":"2021","unstructured":"Mukherjee, S., Sanchez-Bernabeu, A., Demmers, L. C., Wu, W. & Heck, A. J. R. The HLA ligandome comprises a limited repertoire of O-GlcNAcylated antigens preferentially associated With HLA-B*07:02. Front. Immunol. 12, 796584 (2021).","journal-title":"Front. Immunol."},{"key":"39270_CR29","doi-asserted-by":"publisher","first-page":"100018","DOI":"10.1074\/mcp.TIR120.002216","volume":"20","author":"DJ Geiszler","year":"2021","unstructured":"Geiszler, D. J. et al. PTM-shepherd: analysis and summarization of post-translational and chemical modifications from open search results. Mol. Cell. Proteom. 20, 100018 (2021).","journal-title":"Mol. Cell. Proteom."},{"key":"39270_CR30","doi-asserted-by":"publisher","first-page":"100205","DOI":"10.1016\/j.mcpro.2022.100205","volume":"21","author":"DA Polasky","year":"2022","unstructured":"Polasky, D. A., Geiszler, D. J., Yu, F. & Nesvizhskii, A. I. Multiattribute glycan identification and FDR control for glycoproteomics. Mol. Cell. Proteom. 21, 100205 (2022).","journal-title":"Mol. Cell. Proteom."},{"key":"39270_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13404","volume":"7","author":"M Bassani-Sternberg","year":"2016","unstructured":"Bassani-Sternberg, M. et al. Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry. Nat. Commun. 7, 13404 (2016).","journal-title":"Nat. Commun."},{"key":"39270_CR32","doi-asserted-by":"publisher","first-page":"e002071","DOI":"10.1136\/jitc-2020-002071","volume":"9","author":"A Marcu","year":"2021","unstructured":"Marcu, A. et al. HLA ligand atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy. J. Immunother. Cancer 9, e002071 (2021).","journal-title":"J. Immunother. Cancer"},{"key":"39270_CR33","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s40425-019-0769-8","volume":"7","author":"A Newey","year":"2019","unstructured":"Newey, A. et al. Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment. J. Immunother. Cancer 7, 309 (2019).","journal-title":"J. Immunother. Cancer"},{"key":"39270_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14968-9","volume":"11","author":"C Chong","year":"2020","unstructured":"Chong, C. et al. Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomes. Nat. Commun. 11, 1293 (2020).","journal-title":"Nat. Commun."},{"key":"39270_CR35","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1074\/mcp.TIR117.000383","volume":"17","author":"C Chong","year":"2018","unstructured":"Chong, C. et al. High-throughput and sensitive immunopeptidomics platform reveals profound interferon\u03b3-mediated remodeling of the human leukocyte antigen (HLA) ligandome. Mol. Cell. Proteom. 17, 533\u2013548 (2018).","journal-title":"Mol. Cell. Proteom."},{"key":"39270_CR36","doi-asserted-by":"publisher","first-page":"2000160","DOI":"10.1002\/pmic.202000160","volume":"21","author":"SH Ramarathinam","year":"2021","unstructured":"Ramarathinam, S. H., Ho, B. K., Dudek, N. L. & Purcell, A. W. HLA class II immunopeptidomics reveals that co\u2010inherited HLA\u2010allotypes within an extended haplotype can improve proteome coverage for immunosurveillance. Proteomics 21, 2000160 (2021).","journal-title":"Proteomics"},{"key":"39270_CR37","doi-asserted-by":"publisher","first-page":"100032","DOI":"10.1074\/mcp.RA120.002201","volume":"20","author":"G Forlani","year":"2021","unstructured":"Forlani, G. et al. CIITA-transduced glioblastoma cells uncover a rich repertoire of clinically relevant tumor-associated HLA-II antigens. Mol. Cell. Proteom. 20, 100032 (2021).","journal-title":"Mol. Cell. Proteom."},{"key":"39270_CR38","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1038\/s41587-019-0289-6","volume":"37","author":"J Racle","year":"2019","unstructured":"Racle, J. et al. Robust prediction of HLA class II epitopes by deep motif deconvolution of immunopeptidomes. Nat. Biotechnol. 37, 1283\u20131286 (2019).","journal-title":"Nat. Biotechnol."},{"key":"39270_CR39","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1093\/glycob\/cwz080","volume":"30","author":"WS York","year":"2020","unstructured":"York, W. S. et al. GlyGen: computational and informatics resources for glycoscience. Glycobiology 30, 72\u201373 (2020).","journal-title":"Glycobiology"},{"key":"39270_CR40","doi-asserted-by":"publisher","unstructured":"Colley, K. J. et al. Cellular Organization of Glycosylation. 41\u201349 (Cold Spring Harbor Laboratory Press, 2015). https:\/\/doi.org\/10.1101\/glycobiology.3e.004.","DOI":"10.1101\/glycobiology.3e.004"},{"key":"39270_CR41","doi-asserted-by":"publisher","first-page":"9611","DOI":"10.1073\/pnas.152345899","volume":"99","author":"O Werdelin","year":"2002","unstructured":"Werdelin, O., Meldal, M. & Jensen, T. Processing of glycans on glycoprotein and glycopeptide antigens in antigen-presenting cells. Proc. Natl Acad. Sci. USA 99, 9611\u20139613 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"39270_CR42","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1074\/jbc.M706237200","volume":"283","author":"E Kario","year":"2008","unstructured":"Kario, E., Tirosh, B., Ploegh, H. L. & Navon, A. N-linked glycosylation does not impair proteasomal degradation but affects class I major histocompatibility complex presentation. J. Biol. Chem. 283, 244\u2013254 (2008).","journal-title":"J. Biol. Chem."},{"key":"39270_CR43","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/icb.2008.48","volume":"86","author":"AW Purcell","year":"2008","unstructured":"Purcell, A. W., Driel, I. R. & Gleeson, P. A. Impact of glycans on T\u2010cell tolerance to glycosylated self\u2010antigens. Immunol. Cell Biol. 86, 574\u2013579 (2008).","journal-title":"Immunol. Cell Biol."},{"key":"39270_CR44","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1007\/s00109-009-0526-4","volume":"87","author":"J Petersen","year":"2009","unstructured":"Petersen, J., Purcell, A. W. & Rossjohn, J. Post-translationally modified T cell epitopes: immune recognition and immunotherapy. J. Mol. Med. 87, 1045 (2009).","journal-title":"J. Mol. Med."},{"key":"39270_CR45","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.3389\/fimmu.2018.01716","volume":"9","author":"D Gfeller","year":"2018","unstructured":"Gfeller, D. & Bassani-Sternberg, M. Predicting antigen presentation\u2014what could we learn from a million peptides? Front. Immunol. 9, 1716 (2018).","journal-title":"Front. Immunol."},{"key":"39270_CR46","doi-asserted-by":"publisher","first-page":"835454","DOI":"10.3389\/fimmu.2022.835454","volume":"13","author":"S Kaabinejadian","year":"2022","unstructured":"Kaabinejadian, S. et al. Accurate MHC motif deconvolution of immunopeptidomics data reveals a significant contribution of DRB3, 4 and 5 to the total DR immunopeptidome. Front. Immunol. 13, 835454 (2022).","journal-title":"Front. Immunol."},{"key":"39270_CR47","doi-asserted-by":"publisher","first-page":"W449","DOI":"10.1093\/nar\/gkaa379","volume":"48","author":"B Reynisson","year":"2020","unstructured":"Reynisson, B., Alvarez, B., Paul, S., Peters, B. & Nielsen, M. NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data. Nucleic Acids Res. 48, W449\u2013W454 (2020).","journal-title":"Nucleic Acids Res."},{"key":"39270_CR48","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41587-022-01464-2","volume":"41","author":"A Kacen","year":"2023","unstructured":"Kacen, A. et al. Post-translational modifications reshape the antigenic landscape of the MHC I immunopeptidome in tumors. Nat. Biotechnol. 41, 239\u2013251 (2023).","journal-title":"Nat. Biotechnol."},{"key":"39270_CR49","doi-asserted-by":"publisher","first-page":"764462","DOI":"10.3389\/fimmu.2021.764462","volume":"12","author":"P Symonds","year":"2021","unstructured":"Symonds, P. et al. Citrullinated epitopes identified on tumour MHC class II by peptide elution stimulate both regulatory and Th1 responses and require careful selection for optimal anti-tumour responses. Front. Immunol. 12, 764462 (2021).","journal-title":"Front. Immunol."},{"key":"39270_CR50","doi-asserted-by":"publisher","first-page":"10922","DOI":"10.1021\/jacs.5b06586","volume":"137","author":"F Marino","year":"2015","unstructured":"Marino, F. et al. Extended O-GlcNAc on HLA class-I-bound peptides. J. Am. Chem. Soc. 137, 10922\u201310925 (2015).","journal-title":"J. Am. Chem. Soc."},{"key":"39270_CR51","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/s41592-020-00985-5","volume":"17","author":"L Lu","year":"2020","unstructured":"Lu, L., Riley, N. M., Shortreed, M. R., Bertozzi, C. R. & Smith, L. M. O-Pair Search with MetaMorpheus for O-glycopeptide characterization. Nat. Methods 17, 1133\u20131138 (2020).","journal-title":"Nat. Methods"},{"key":"39270_CR52","doi-asserted-by":"publisher","first-page":"D442","DOI":"10.1093\/nar\/gky1106","volume":"47","author":"Y Perez-Riverol","year":"2019","unstructured":"Perez-Riverol, Y. et al. The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res. 47, D442\u2013D450 (2019).","journal-title":"Nucleic Acids Res."},{"key":"39270_CR53","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1021\/pr049882h","volume":"3","author":"R Craig","year":"2004","unstructured":"Craig, R., Cortens, J. P. & Beavis, R. C. Open source system for analyzing, validating, and storing protein identification data. J. Proteome Res. 3, 1234\u20131242 (2004).","journal-title":"J. Proteome Res."},{"key":"39270_CR54","doi-asserted-by":"publisher","first-page":"2534","DOI":"10.1093\/bioinformatics\/btn323","volume":"24","author":"D Kessner","year":"2008","unstructured":"Kessner, D., Chambers, M., Burke, R., Agus, D. & Mallick, P. ProteoWizard: open source software for rapid proteomics tools development. Bioinformatics 24, 2534\u20132536 (2008).","journal-title":"Bioinformatics"},{"key":"39270_CR55","doi-asserted-by":"publisher","first-page":"D158","DOI":"10.1093\/nar\/gkw1099","volume":"45","author":"The UniProt Consortium.","year":"2017","unstructured":"The UniProt Consortium. UniProt: the universal protein knowledgebase. Nucleic Acids Res. 45, D158\u2013D169 (2017).","journal-title":"Nucleic Acids Res."},{"key":"39270_CR56","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1021\/acs.jproteome.0c00544","volume":"20","author":"GC Teo","year":"2021","unstructured":"Teo, G. C., Polasky, D. A., Yu, F. & Nesvizhskii, A. I. Fast deisotoping algorithm and its implementation in the MSFragger search engine. J. Proteome Res. 20, 498\u2013505 (2021).","journal-title":"J. Proteome Res."},{"key":"39270_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17921-y","volume":"11","author":"F Yu","year":"2020","unstructured":"Yu, F. et al. Identification of modified peptides using localization-aware open search. Nat. Commun. 11, 4065 (2020).","journal-title":"Nat. Commun."},{"key":"39270_CR58","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/s41592-020-0912-y","volume":"17","author":"F da Veiga Leprevost","year":"2020","unstructured":"da Veiga Leprevost, F. et al. Philosopher: a versatile toolkit for shotgun proteomics data analysis. Nat. Methods 17, 869\u2013870 (2020).","journal-title":"Nat. Methods"},{"key":"39270_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-13-S16-S1","volume":"13","author":"K Ma","year":"2012","unstructured":"Ma, K., Vitek, O. & Nesvizhskii, A. I. A statistical model-building perspective to identification of MS\/MS spectra with PeptideProphet. BMC Bioinformatics 13, S1 (2012).","journal-title":"BMC Bioinformatics"},{"key":"39270_CR60","doi-asserted-by":"publisher","first-page":"4646","DOI":"10.1021\/ac0341261","volume":"75","author":"AI Nesvizhskii","year":"2003","unstructured":"Nesvizhskii, A. I., Keller, A., Kolker, E. & Aebersold, R. A Statistical Model for Identifying Proteins by Tandem Mass Spectrometry. Anal. Chem. 75, 4646\u20134658 (2003).","journal-title":"Anal. Chem."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-39270-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-39270-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-39270-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,12]],"date-time":"2023-06-12T12:02:43Z","timestamp":1686571363000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-39270-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,12]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["39270"],"URL":"https:\/\/doi.org\/10.1038\/s41467-023-39270-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,12]]},"assertion":[{"value":"7 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3461"}}